Why the study?
Is percutaneous left atrial appendage closure feasible and safe in solid-organ transplant recipients with atrial fibrillation?
Is percutaneous left atrial appendage closure feasible and safe in solid-organ transplant recipients with atrial fibrillation?
This editorial emphasizes the feasibility and safety of LAA closure in solid-organ transplant recipients, a high-hemorrhagic-risk population typically excluded from clinical trials, while highlighting the specific anatomic challenges in heart transplant patients.
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Cabrera et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: